Company: TAK
Filing Date: 2025-05-08
Form Type: 6-K
Source: 0001395064-25-000048
Chunk: 5

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-05-08
Form: 6-K
Chunk 5
---
     |  10.9 |     |     |          |  9.3 | % |     |          |     |  4.7 | %                         |
| Total                          |          |                           | 4,263.8 |     |     | 4,581.6 |     |     |                  |     | 317.8 |     |     |          |  7.5 | % |     |          |     |  2.9 | %                         |

* Other includes the Middle East, Oceania and Africa.

#### Revenue by Business Area
The following shows revenue by business area:

|               | Revenue: | For the fiscal year ended 
 March 31,                 |    2024 |     |     |    2025 |     |     | Amount of Change | AER |       |     |     | % Change |       |   |     | % Change | CER |       | Billion JPY or percentage |
|:--------------|:---------|:--------------------------|--------:|:----|:----|--------:|:----|:----|:-----------------|:----|------:|:----|:----|:---------|------:|:--|:----|:---------|:----|------:|:--------------------------|
| GI            |          |                           | 1,216.2 |     |     | 1,357.0 |     |     |                  |     | 140.8 |     |     |          |  11.6 | % |     |          |     |   6.8 | %                         |
| Rare Diseases |          |                           |   688.4 |     |     |   752.8 |     |     |                  |     |  64.4 |     |     |          |   9.4 | % |     |          |     |   4.6 | %                         |
| PDT           |          |                           |   903.7 |     |     | 1,032.7 |     |     |                  |     | 129.0 |     |     |          |  14.3 | % |     |          |     |   8.6 | %                         |
| Oncology      |          |                           |   462.4 |     |     |   560.4 |     |     |                  |     |  98